Log In
Print this Print this

RetnaGene LR

  Manage Alerts
Collapse Summary General Information
Company Laboratory Corp. of America Holdings
Description Test to assess the risk of developing age-related macular degeneration (AMD)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationOphthalmic, Diagnostic
Indication DetailsPredict the genetic risk of a patient with dry or early stage age-related macular degeneration (AMD)
Regulatory Designation
PartnerValeant Pharmaceuticals International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone









Get a free BioCentury trial today